Business Transformation

Every pharma transformation project fails the same way: a new strategy is approved, but the operating model that has to deliver it is unchanged. Your field team still runs on 90-day planning cycles, your marketing team still waits on MLR gates, and your analytics team still reports last quarter’s truth three weeks late. We redesign the operating model first — org, process, tech, and metrics — so the new strategy has a chance of actually shipping.

Current-state diagnosis, future-proof strategy development, alignment to organizational goals and launch commitments. We build the strategy around your portfolio reality, not a generic framework.

Our strategic planning begins with a rigorous assessment of your commercial operating model — where decisions get made, where value gets lost, and where the organization is misaligned with market reality. We then co-create a transformation roadmap with your leadership team that sequences initiatives against business priorities, resource capacity, and risk tolerance.

End-to-end commercial process mapping. We identify bottlenecks, standardize where it helps, and digitize where it saves cycle time. Every process change is tested against your regulatory and compliance constraints.

We walk your processes from end to end — from brand planning through medical review to field execution — measuring cycle times, handoff delays, and rework rates at every stage. The output is a prioritized improvement plan that balances quick wins with structural redesign, always validated against your compliance requirements before implementation.

Role clarity, capability uplift, leadership coaching, change communications. We are embedded through the transition — not just during the kickoff workshop.

Transformation fails when people are told to change without being equipped to change. We design change programs that start with honest stakeholder analysis — who gains, who loses, who’s quietly resistant — then build targeted interventions: manager coaching, team workshops, skills academies, and communication cadences that sustain momentum long after the consultants leave.

Pod-based operating model, RACI redesign, reporting-line realignment, span-of-control analysis. Structures that match how work actually flows, not how the org chart was inherited.

Most pharma org charts are archaeological records of past acquisitions and political compromises. We redesign structures around value streams — how decisions actually need to flow to get a product to market, a field team mobilized, or a compliance review completed. The result is an operating model that reduces decision latency and eliminates the duplicated roles that slow you down.

Regulatory, operational, and commercial risk surfaced early. Mitigation plans with owners and escalation paths — not a risk register nobody reads.

We integrate risk management into the operating rhythm of your transformation — not as a separate compliance exercise but as a standing agenda item in every workstream review. Each risk gets an owner, a trigger threshold, and a pre-approved response plan, so your team can move fast without moving recklessly.

The KPI framework that holds everyone accountable — and the reporting cadence that makes the metrics visible enough to act on.

We design balanced scorecards that connect leading indicators to lagging outcomes, so your teams can see whether their daily actions are driving the results that matter. Our performance frameworks include automated dashboards, weekly review rituals, and escalation protocols that turn data into decisions — not just slides for the quarterly business review.

• ➔ A new BU leader is inheriting a portfolio and needs to redesign the operating model in 90 days
• ➔ A launch is six months out and the team is not ready
• ➔ The field force is flying blind because commercial ops has not caught up to the strategy
• ➔ A merger or integration is about to close and the operating model has to be unified
• ➔ A CEO or commercial leader has lost confidence in the current cadence